Doctor profile · Federal record
Dr. Alison Black, M.D.
Dermatology Physician (CMS: Dermatology) · Specialist · Irving, TX
- NPI 1285653584
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 35 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
440 W Lyndon B Johnson Fwy, 365
Irving, TX 750633707
(972) 432-0300
fax (972) 432-0874
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- March 24, 2009
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #J1878
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285653584. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,302
Distinct HCPCS
10
Medicare allowed
$207,896
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,210 | 185 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 457 | 280 | $127 | |
17000 |
Destruction of precancer skin growth, 1 growth | 387 | 264 | $49 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 371 | 292 | $90 | |
17110 |
Destruction of skin growth, 1-14 growths | 337 | 243 | $111 | |
11102 |
Biopsy of related skin growth, first growth | 202 | 174 | $80 | |
11103 |
Biopsy of related skin growth, each additional growth | 48 | 35 | $50 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 43 | 43 | $112 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 36 | 15 | $1 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 35 | 26 | $170 |
In context: peer comparison
Among 4 peers in Irving Dermatology Physician, average services per provider: 134. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$2,149
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 22 | $589.22 | |
| Janssen Biotech, INC. | 11 | $286.42 | |
| Genzyme Corporation | 9 | $207.24 | |
| Amgen INC. | 11 | $203.55 | |
| Revance Therapeutics, INC. | 2 | $181.92 | |
| Novartis Pharmaceuticals Corporation | 5 | $120.43 | |
| Galderma Laboratories, L.P. | 6 | $108.52 | |
| Incyte Corporation | 4 | $88.61 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $66.26 | |
| Regeneron Healthcare Solutions, INC. | 2 | $64.36 | |
| Pfizer INC. | 3 | $49.54 | |
| Sun Pharmaceutical Industries INC. | 1 | $30.22 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $28.14 | |
| Verrica Pharmaceuticals INC. | 1 | $26.68 | |
| Ucb, INC. | 1 | $25.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
213
Patients
94
Total drug cost
$56,717
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 44 | 31 | $533 |
| Ketoconazole | Generic | 42 | 18 | $1,210 |
| Clobetasol Propionate | Generic | 35 | 17 | $2,742 |
| Mupirocin | Generic | 19 | 17 | $251 |
| Dutasteride | Generic | 18 | 0 | $165 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 17 | 11 | $309 |
| Fluconazole | Generic | 15 | 0 | $196 |
| Dupixent Pen (Dupilumab) | Brand | 12 | 0 | $50,094 |
| Metronidazole | Generic | 11 | 0 | $1,217 |
Frequently asked questions
What is Dr. Alison Black's medical specialty?
Dr. Alison Black practices Dermatology Physician in Irving, TX.
Where does Dr. Alison Black practice?
Dr. Alison Black practices at 440 W Lyndon B Johnson Fwy, Irving, TX 750633707. Office phone: 9724320300.
What is Dr. Alison Black's NPI?
Dr. Alison Black's National Provider Identifier (NPI) is 1285653584, issued by NPPES.
Does Dr. Alison Black accept Medicare assignment?
Yes. Dr. Alison Black accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alison Black commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.